E-Mentoring in IBD
Wearables & IBD flares
March 11, 2025
Thiopurine withdrawal during VDZ Tx for UC
February 25, 2025
Oral vancomycin & PSC-IBD
February 11, 2025
VTE in kids with IBD
January 20, 2025
GLP-1s & IBD
January 7, 2025
Biologic intolerance/failure & subsequent response
December 9, 2024
IBD & fracture risk
November 26, 2024
Very late-onset IBD
November 19, 2024
IFX rescue for ASUC
October 28, 2024
JAK inhibitors & MACE
October 15, 2024
Tofacitinib & ASUC
September 30, 2024
Top-down vs. accelerated step-up for new CD
September 16, 2024
Triple combo therapy in CD
August 30, 2024
Re-resection rates & disease recurrence CD
August 12, 2024
EEN vs. steroids in pediatric CD
July 30, 2024
Immunosuppression & cancer risk
July 9, 2024
Colectomy & kidney disease
June 24, 2024
LDA safety in pregnancy
June 10, 2024
CKD & IBD
May 28, 2024
Pre-IPAA antibiotics & pouchitis
May 13, 2024
Risk of infection in IBD with IL-targeting agents
April 29, 2024
C. difficile trends in hospitalized IBD patients
April 15, 2024
Perianal CD relapse after stopping anti-TNF
March 25, 2024
Biologics & penetrating CD
March 11, 2024
UST, pregnancy & infant health
February 26, 2024
Medication use before IBD Dx
February 12, 2024
Abdominal pain in IBD remission
January 29, 2024
Efficacy of biologics—1st- & 2nd-Line Tx of IBD
January 16, 2024
VDZ dosing for early non-responders
January 2, 2024
UST & VDZ exposure during pregnancy
December 11, 2023
Etiology of CD of the pouch
November 27, 2023
MC & RA
November 13, 2023
CVD link to IBD diagnosis
October 31, 2023
Immunosuppression & cancer recurrence
October 24, 2023
Preop risk factors for adverse events in bowel resection
September 27, 2023
Sx vs. medical Tx for ileocecal CD
September 18, 2023
IA-VAT & biologics in IBD
September 5, 2023
Safety of biologics & cancer
August 29, 2023
Microscopic colitis and MACE
August 15, 2023
Biologics & internal fistulizing CD
July 18, 2023
Histologic assessment using AI
July 5, 2023
Malnutrition risk in new Dx IBD
June 20, 2023
Stress & UC relapses
May 16, 2023
Advanced therapy & serious infections in IBD
May 2, 2023
IBD & risk of respiratory Sx
April 18, 2023
Cancer treatment & IBD relapse
April 4, 2023
Antibiotics & lifespan risk of IBD
March 21, 2023
Intestinal barrier healing & IBD outcomes
March 7, 2023
Shared decision making & CD treatment choices
February 21, 2023
Risk of active IBD during pregnancy
February 7, 2023
IUS to assess UC treatment response
January 24, 2023
NSAIDs & IBD relapse
January 10, 2023
Perianal CD & colorectal/anal cancer
December 20, 2022
Reintroduction of infliximab in CD
December 6, 2022
Celiac disease & IBD
November 22, 2022
Subclinical inflammation & CD progression
November 8, 2022
Predicting relapse after stopping anti-TNF
October 18, 2022
Corticosteroids & perinatal outcomes
October 4, 2022
Histological activity & relapse in UC
September 20, 2022
Anxiety / depression & IBD outcomes
September 7, 2022
Cigarettes & colorectal neoplasia in IBD
August 23, 2022
Impact of in utero exposure to IBD treatment
August 9, 2022
COVID-19 vaccination in IBD patients
July 19, 2022
Proactive TDM vs. conventional IBD management
July 12, 2022
Postop complications & anti-TNFs
June 21, 2022
ARFID & IBD
June 6, 2022
Pediatric-onset IBD & risk of cancer
May 24, 2022
Impact of HIV on IBD
May 10, 2022
Disease duration & efficacy of biologics
April 26, 2022
COVID-19 vaccine efficacy in IBD
April 12, 2022
Risk of subsequent anti-TNF antibodies
March 29, 2022
Predictors of pediatric CD relapse
March 15, 2022
Rectal cancer in the diverted rectum
February 22, 2022
Impact of fluctuating antibodies to infliximab
February 8, 2022
Mortality in older IBD inpatients
December 1, 2020
Assisted reproduction in IBD
January 4, 2022
Digital health & IBD
December 21, 2021
Tofacitinib for ASUC
December 7, 2021
ER opioid use for IBD patients
November 23, 2021
Risk of surgery in the era of biologics
November 9, 2021
PPI use & infliximab
November 2, 2021
SARS-CoV-2 vaccine & IBD
October 5, 2021
Efficacy of IBD diets
September 21, 2021
Antibiotics & anti-TNFs
September 15, 2021
CD recurrence after ileocolonic resection
August 28, 2021
IBD & extraintestinal cancers
August 10, 2021
Psychological comorbidities & IBD
July 17, 2021
IBD meds & COVID-19 outcomes
July 20, 2021
Anxiety & depression in IBD
June 22, 2021
Perianal fistula-related cancer in CD
June 15, 2021
Impact of pandemic on management of ASUC
May 18, 2021
Risk factors for advanced colorectal neoplasia
May 4, 2021
Colorectal strictures in UC
April 20, 2021
PPI use & IBD outcomes
April 6, 2021
In utero biologic exposure & infant infection risk
March 23, 2021
PICaSSO Endoscopic Score
March 15, 2021
Obesity & CD outcomes
February 23, 2021
Socioeconomic status & IBD outcomes
February 9, 2021
Anti-TNF therapy & demyelination
January 26, 2021
IBD & risk of dementia
January 12, 2021
Combination therapy in IBD
December 15, 2020
Urolithiasis risk in IBD
December 1, 2020
Outcomes with elderly-onset IBD
November 18, 2020
Risk of IBD with pro-inflammatory diets
November 3, 2020
Deep remission of early CD & outcomes
October 20, 2020
GI Symptoms, Stool Viral RNA in COVID-19 Patients
October 6, 2020
IPAA failure rates among IC patients
September 22, 2020
Relapse rates after vedolizumab discontinuation
September 8, 2020
Predictors of successful fistula management
August 6, 2020
Predictors of successful fistula management
January 28, 2020
Early IBD diagnosis & course of disease
July 22, 2020
Frailty & immunomodulator infection risk
July 14, 2020
Anti-TNFs & IBD-related arterial disease
June 16, 2020
Aspirin & IBD outcomes
June 2, 2020
IBD & risk of Type 2 diabetes
May 19, 2020
Cancer therapy & risk of IBD relapse
May 5, 2020
Efficacy of anti-TNFs for internal fistulae in CD
April 21, 2020
Early life exposure to antibiotics & risk of CD
March 24, 2020
Serum protein test & remission in CD
March 10, 2020
Extracolonic cancers after total colectomy in CD
February 25, 2020
Poor sleep quality & CD outcomes
February 11, 2020
Risk of capsule retention in CD patients
January 28, 2020
HLA-DQA1*05 Allele & Risk of Anti-TNF Immunogenicity
January 14, 2020